Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of protease inhibitors and targeted cancer therapies. Its boronic acid functional group enables reversible interactions with biological targets such as enzymes, making it valuable in designing inhibitors for serine proteases. Commonly employed in Suzuki-Miyaura cross-coupling reactions to construct biaryl frameworks found in bioactive molecules. Also utilized in the preparation of boron-containing drugs that benefit from enhanced binding affinity and metabolic stability. Its structure allows for further functionalization, supporting use in combinatorial chemistry and drug discovery research.